Rockefeller Capital Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-6,102
| Closed | -$620K | – | 4756 |
|
|
2025
Q4 | $620K | Buy |
6,102
+55
| +0.9% | +$4.42K | ﹤0.01% | 1787 |
|
|
2025
Q3 | $331K | Buy |
+6,047
| New | +$302K | ﹤0.01% | 1968 |
|
|
2024
Q3 | – | Sell |
-57,726
| Closed | -$2.44M | – | 1631 |
|
|
2024
Q2 | $2.44M | Buy |
57,726
+35,055
| +155% | +$1.93M | 0.01% | 902 |
|
|
2024
Q1 | $1.57M | Buy |
22,671
+412
| +2% | +$26.1K | ﹤0.01% | 1112 |
|
|
2023
Q4 | $1.65M | Buy |
22,259
+10,613
| +91% | +$696K | 0.01% | 981 |
|
|
2023
Q3 | $794K | Buy |
11,646
+2,398
| +26% | +$203K | ﹤0.01% | 1164 |
|
|
2023
Q2 | $868K | Buy |
9,248
+5,816
| +169% | +$454K | ﹤0.01% | 1145 |
|
|
2023
Q1 | $232K | Sell |
3,432
-67
| -2% | -$4.31K | ﹤0.01% | 1735 |
|
|
2022
Q4 | $172K | Sell |
3,499
-1,409
| -29% | -$57.6K | ﹤0.01% | 1735 |
|
|
2022
Q3 | $158K | Sell |
4,908
-133
| -3% | -$5.48K | ﹤0.01% | 1752 |
|
|
2022
Q2 | $197K | Sell |
5,041
-44
| -0.9% | -$2.35K | ﹤0.01% | 1641 |
|
|
2022
Q1 | $355K | Buy |
5,085
+1,938
| +62% | +$142K | ﹤0.01% | 1458 |
|
|
2021
Q4 | $244K | Sell |
3,147
-7,654
| -71% | -$675K | ﹤0.01% | 1572 |
|
|
2021
Q3 | $1.03M | Sell |
10,801
-11,495
| -52% | -$1.21M | 0.01% | 994 |
|
|
2021
Q2 | $2.77M | Buy |
22,296
+5,671
| +34% | +$677K | 0.02% | 630 |
|
|
2021
Q1 | $2.19M | Buy |
16,625
+6,513
| +64% | +$892K | 0.01% | 556 |
|
|
2020
Q4 | $1.34M | Buy |
10,112
+8,262
| +447% | +$999K | 0.01% | 618 |
|
|
2020
Q3 | $188K | Sell |
1,850
-2,816
| -60% | -$243K | ﹤0.01% | 1056 |
|
|
2020
Q2 | $406K | Buy |
4,666
+2,364
| +103% | +$189K | ﹤0.01% | 772 |
|
|
2020
Q1 | $134K | Buy |
2,302
+911
| +65% | +$74K | ﹤0.01% | 930 |
|
|
2019
Q4 | $129K | Buy |
1,391
+41
| +3% | +$3.6K | ﹤0.01% | 891 |
|
|
2019
Q3 | $122K | Buy |
1,350
+555
| +70% | +$63.2K | ﹤0.01% | 736 |
|
|
2019
Q2 | $94K | Buy |
795
+23
| +3% | +$2.32K | ﹤0.01% | 703 |
|
|
2019
Q1 | $67K | Buy |
772
+72
| +10% | +$6.13K | ﹤0.01% | 848 |
|
|
2018
Q4 | $44K | Buy |
+700
| New | +$48K | ﹤0.01% | 536 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Rockefeller Capital Management's EXAS Position: Q1 2026 in Review
Rockefeller Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 6,102 shares — an estimated $620K sold.
Rockefeller Capital Management first reported a position in EXAS in Q4 2018 and held it in 25 quarters. The position peaked at $2.77M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Rockefeller Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Rockefeller Capital Management sold 6,102 Exact Sciences shares in Q1 2026, an estimated $620K.
- Rockefeller Capital Management first reported a position in Exact Sciences in Q4 2018 and held it in 25 quarters.
- Rockefeller Capital Management's Exact Sciences position peaked at $2.77M in Q2 2021.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.